Effects of Piper sarmentosum (kaduk) water extract on adiponectin and blood glucose levels in ovariectomy-induced obese rats

Research Journal of Medicinal Plant

Volumn 3, Issue 3, 2009, Pages 109-115

  Azlina, A Aida ^a   Farihah, S ^a   Qodriyah, M S ^a   Nur Azlina, M F ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Adiponectin; Blood glucose; Obesity; Ovariectomy; Piper sarmentosum

Indexed keywords

ADIPONECTIN; GLUCOSE; GLYCYRRHIZIC ACID; PIPER SARMENTOSUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; INTRAABDOMINAL FAT; MEDICINAL PLANT; NONHUMAN; OBESITY; OVARIECTOMY; PIPER SARMENTOSUM; RAT; SHAM PROCEDURE; THERAPY EFFECT; TRADITIONAL MEDICINE;

PIPER SARMENTOSUM; RATTUS;

EID: 70350626539     PISSN: 18193455     EISSN: None     Source Type: Journal    
DOI: 10.3923/rjmp.2009.109.115     Document Type: Article

References (24)

1. Al-Wahaibi, A., 2007. The role of 11 beta-hydroxysteroid dehydrogenase type-1 (11BHSD-1) in ovariectomy-induced obesity rats and its modulation by estrogen replacement theraphy, glycyrrhizic acid and kacip fatimah. Ph.D. Thesis, Unitersiti Kebangsaan Malaysia.
2. Almonte, J., S. Harbarum, A. Richter and H. Dong, 2003. Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism, 52: 958-963.
3. Arita, Y., S. Kihara, N. Ouchi, M. Takahashi, K. Maeda and K. Miyagawa et al., 1999. Paradoxical decrease o f an adipose-specific protein, adiponectin, in obesity. Biochem. Bioph., Res. Co., 257: 79-83.
4. Berg, A.H., T.P. Combs and P.E. Scherer, 2002. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrin. Met., 13: 84-89.
5. Berger, J., M. Tanen, A. Elbrecht, A. Hermanowski-Vosatka, D.E. Moller, S.D. Wright and R. Thieringer, 2001. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem., 276: 12629-12635.
6. Chanwitheesuk, A., A. Teerawutgulrag and N. Rakariyatham, 2005. Screening of antioxidant activity and antioxidant compounds of some edible plants of Thailand. Food Chem., 92: 491-497.
7. Chu, S.C., Y.C. Chou, J.Y. Liu CH. Chen, J.C. Shyu and F.P. Chou, 1999. Fluctuation of serum leptin level in rats after ovariectomy and the Influence of estrogen supplement. Life Sci., 64: 2299-2306.
8. Comuzzie, A.G., T. Funahashi, G. Sonnenberg, L.J. Martin and H.J. Jacob et al., 2001. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J. Clin. Endocr. Metab., 86: 4321-4325.
9. Greenberg, A.S. and M.L. McDaniel, 2002. Identifying the links between obesity, insulin resistance and ?-cell ftiriction: Potential role of adipocyte -derived cytokines in the pathogenesis of type-2 diabetes. Eur. J. Clin. Invest., 32.: 24-34.
10. Hara, K., P. Boutin, Y. Mori, K. Tobe and C. Dina et al., 2002. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type-2 diabetes in the Japanese population. Diabetes, 51: 536-540.
11. Havel, P. J., 2002. Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein and adiponectin. Curr. Opin. Lipidol., 13: 51-59.
12. Hotta, K., T. Funahashi, N.L. Bodkin, H.K. Ortmeyer, Y. Arita, B.C. Hansen and Y. Matsuzawa, 2001. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type-2 diabetes in rhesus monkeys. Diabetes, 50: 1126-1126.
13. Kano, S. and M. Doi, 2006. NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, accelerates the expression of UCP3 messenger RNA and ameliorates obesity in ovariectomized rats. Metabol. Clin. Exp., 55: 151-158.
14. Lindsay, R.S., T. Funahashi, R.L. Hanson, Y. Matsuzawa and S. Tanaka et al., 2002. Adiponectin and development of type-2 diabetes in the Pima Indian population. Lancet, 360: 57-58.
15. Masuzaki, H., J. Peterson, H. Shinyama, N.M. Morton, J.J. Mullins, J.R. Seckl and F.S. Flier, 2001. A transgenic model of visceral obesity and the metabolic syndrome. Science, 294: 2166-2170.
16. Nadler, S.T., J.P. Stoehr, K.L. Schueler, G. Tanimoto, B.S. Yandell and A.D. Attie, 2000. The expression of adipogenic genes is decreased in obesity and diabetes niellitus. Proc. Natl. Acad. Sci. USA, 1997: 11371-11376.
17. Najib Nik, A., N. Rahman, T. Furuta, S. Kojima, K. Takane and M.A. Mohd, 1999. Antimalarial activity of extracts of Malaysian medicinal plants. Ethnopharmacol., 64: 249-254.
18. Peungvicha, P., S.S. Thirawarapan, R. Temsiririrkkul, H. Watanabe, J.K. Prasain and S. Kodata, 1998, Hypoglycemic effect of the water extract of Piper sarmentosum in rats. J. Ethnopharmacol., 60: 27-32.
19. Ridtitid, W., W. Rattanaporn, P. Thaina, S. Chittrakam and M. Sunbhanich, 1998. Neuromuscular blocking activity of methanolic extract of Piper sarmentosum leaves in the rat phrenic nerve-hemidiaphragm preparation. J. Ethnopharmacol., 61: 135-142.
20. Rolland, Y.M., M.T. Haren, P. Patrick, W.A. Banks, T.K. Malmstrom, D.K. Miller and J.E. Morley, 2007. Adiponectin levels in obese and non-obese middle-aged African-American Women. Obesity Res. Clin.1 Practice, 1: 27-37.
21. Stefan, N., B. Vozarova, T. Funahashi, Y. Matsuzawa and C. Weyer et al., 2002. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes, 51: 1884-1888.
22. Steppan, C.M. and M.A. Lazar, 2002. Resistin and obesity-associated insulin resistance. Trends Endocrin., Met., 13: 18-23.
23. Tsao, T.S., H.F. Lodish and J. Fruebis, 2002. ACRP30, a new, hormone controlling fat and glucose metabolism. Eur. J. Pharmacol., 440: 213-221.
24. Weyer, C., T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley and P.A. Tataranni, 2001. Hypoadiponectinemia in obesity and type-2 diabetes: Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocr. Metab., 86: 1930-1935.